pharmacodynamics 2

37
PHARMACODYNAMICS (II)

Upload: khalid-aftab-phd

Post on 22-Jan-2018

676 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Pharmacodynamics 2

PHARMACODYNAMICS (II)

Page 2: Pharmacodynamics 2

AIMS AND OBJECTIVES

The topics discussed in this lecture: -

i. Graded dose response curves

ii. Potency and Efficacy

iii.Therapeutic index

iv.Types of antagonism

v. Important definitions

Page 3: Pharmacodynamics 2

GRADED DOSE RESPONSE CURVES

The response to a drug is a graded effect.

Here the magnitude of responses are

plotted against the graded doses.

Determination of :

Efficacy, Potency ,Therapeutic index

Page 4: Pharmacodynamics 2
Page 5: Pharmacodynamics 2
Page 6: Pharmacodynamics 2
Page 7: Pharmacodynamics 2

Potency and Efficacy

Two important properties which can be

determined by graded doze response

curves.

POTENCY: A measure of the amount of

drug necessary to produce an effect of a

given magnitude.

GRADED DOSE RESPONSE CURVES

Page 8: Pharmacodynamics 2

EFFICACY

The magnitude of the response after

occupation of the receptors.

GRADED DOSE RESPONSE CURVES

Page 9: Pharmacodynamics 2

CBA

Page 10: Pharmacodynamics 2
Page 11: Pharmacodynamics 2

THERAPEUTIC INDEX

The ratio between LD50 and ED50 .

LD50 : A dose which is lethal in 50% of

the experimental animals.

Page 12: Pharmacodynamics 2

ED50: A dose which produces a desired

therapeutic effect in 50% of the

experimental animals

THERAPEUTIC INDEX:LD50

ED50

THERAPEUTIC INDEX

Page 13: Pharmacodynamics 2
Page 14: Pharmacodynamics 2

HUMAN BEINGS

Ratio between TD50 and ED50

TD50:A drug dose which produces toxic

effect in 50% of the population

ED50:A drug dose which produces a desired

therapeutic response in 50% of the

population

THERAPEUTIC INDEX

Page 15: Pharmacodynamics 2

THERAPEUTIC INDEX:

TD50

ED50

ED50 = EC50

THERAPEUTIC INDEX

Page 16: Pharmacodynamics 2

Therapeutic index is a measure of the drug

safety.

A large value indicates that there is a wide

margin between doses that are effective and

doses that are toxic ie the drug is safe

EXAMPLE: PENICILLIN

THERAPEUTIC INDEX

Page 17: Pharmacodynamics 2
Page 18: Pharmacodynamics 2

A small value indicates that the margin

between the toxic and effective doses is

small.

The drug can produce toxic effects with

slight increase in the dose

EXAMPLE: WARFARIN

THERAPEUTIC INDEX

Page 19: Pharmacodynamics 2
Page 20: Pharmacodynamics 2

CHEMICAL ANTAGONISM

DIMERCAPROL

ANTACIDS

PROTAMINE

DEFEROXAMINE

HEAVY METALS

HCl (stomach)

HEPARIN

IRON

Chemical interaction

Page 21: Pharmacodynamics 2

PHYSIOLOGICAL ANTAGONISM

HISTAMINE:H1 ADRENALINE:ß2

HISTAMINE: BRONCHOSPASM

ADRENALINE: BRONCHODILATION

Adrenaline Antagonizes Histamine

(Anaphylactic Shock)

Page 22: Pharmacodynamics 2

AGONIST ANTAGONIST

Histamine

Acetylcholine

Epinephrine

Norepinephrine

Chlorpheniramine

Atropine

Propranolol

Tolazoline

The agonist and antagonist compete for the same receptors

PHARMACOLOGICALANTAGONISM

Page 23: Pharmacodynamics 2

PHARMACOLOGICAL ANTAGONISM

Competitive: Maximum effect can be

obtained in the presence of Antagonist

NE TOLAZOLINE

Non competitive: Maximum effect can not

be obtained

NE DIBENAMINE

Page 24: Pharmacodynamics 2

TOLAZOLINE DIBENAMINE

Page 25: Pharmacodynamics 2

BIOCHEMICAL ANTAGONISM

ENZYME INDUCERS

DRUGS DRUGS AFFECTED

Rifampin

Phenytoin

Griseofulvin

Warfarin

Oral contraceptives

Cortisol

Warfarin

Phenobarbital

Page 26: Pharmacodynamics 2

The factors affecting drug actions:

Drug preparations, route of

administration, interaction,

individual difference, allergic

reaction, physiologic and pathologic

status, drug-resistance and

environmental factors.

Page 27: Pharmacodynamics 2

IMPORTANT DEFINITIONS

1. TOLERANCE: Responsiveness

decreases as a consequence of

continued drug administration.

Morphine; Opium

2. TACHYPHYLAXIS: Rapidly developing

tolerance. Ephedrine

Page 28: Pharmacodynamics 2

Ο Ο Ο Ο Ο

DOG’s BLOOD PRESSURE: EPHEDRINE, THE SAME DOSE REPEATED AFTER SHORT

INTERVALS

Page 29: Pharmacodynamics 2

3. IDIOSYNCRASY: Abnormal responses to

drugs due to genetic abnormalities

4. HYPERSENSITIVITY: Allergic

(immunological) responses to drugs

Drug acts as an antigen; TYPE I, II, III, IV

Page 30: Pharmacodynamics 2

5. HYPER REACTIVITY: When the intensity

of the effect of a drug is increased in

comparison to most individuals

Epinephrine → Thyrotoxicosis

Page 31: Pharmacodynamics 2

6. HYPO REACTIVITY: When the intensity

of the effect of a drug is decreased in

comparison to most individuals

Epinephrine → Myxoedeme

Page 32: Pharmacodynamics 2

TOLERANCE, REFARACTORINESS, RESISTANCE

CAUSES:

o Changes in the sensitivity of receptors

o Exhaustion of mediators

o Increased metabolic degradation

o Increased elimination

Page 33: Pharmacodynamics 2

QUESTIONS

Page 34: Pharmacodynamics 2

1. The following are the values of the therapeutic index of five different drugs. Which one of these drugs is most toxic: -

a) 2.5

b) 3.0

c) 3.5

d) 4.0

e) 5.0

Page 35: Pharmacodynamics 2

2. In human beings, the value of Therapeutic index is expressed by the ration: -

a) LD50 / ED50

b) ED50 / LD50

c) TD50 / ED50

d) ED50 / TD50

e) TD50 / LD50

Page 36: Pharmacodynamics 2

3. The mechanism of action of antagonism of

Heparin by Protamine is similar to the

mechanism involved in the antagonism of : -

a) Iron by Deferoxamine

b) Histamine by Omeprazole

c) Acetylcholine by Atropine

d) Histamine by Epinephrine

e) Norepinephrine by Tolazoline

Page 37: Pharmacodynamics 2

4. The antagonism of NE by Tolazoline

is an example of: -

a) Noncompetitive antagonism

b) Competitive antagonism

c) Chemical antagonism

d) Biochemical antagonism

e) Physiological antagonism